The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non–muscle-invasive bladder cancer: A network meta-analysis-Reference-Cited by-同舟云学术

The efficacy and safety outcomes of lower dose BCG compared to intravesical chemotherapy in non–muscle-invasive bladder cancer: A network meta-analysis

Published:2023-06 Issue:6 Volume:41 Page:261-273
ISSN:1078-1439
Container-title:Urologic Oncology: Seminars and Original Investigations
language:en
Short-container-title:Urologic Oncology: Seminars and Original Investigations

Author:

Kawada Tatsushi^ORCID,Yanagisawa Takafumi,Bekku Kensuke,Laukhtina Ekaterina,von Deimling Markus,Chlosta Marcin,Pradere Benjamin,Teoh Jeremy Yuen-Chun,Babjuk Marko,Araki Motoo,Shariat Shahrokh F.

Publisher

Elsevier BV

Subject

Urology,Oncology

Reference33 articles.

1. Epidemiology and risk factors of urothelial bladder cancer;Burger;Eur Urol,2013

2. European association of urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and Carcinoma in Situ);Babjuk;Eur Urol,2022

3. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA/SUO guideline;Chang;J Urol,2016

4. Long-term follow-up of a randomized prospective trial comparing a standard 81 mg dose of intravesical bacille Calmette-Guérin with a reduced dose of 27 mg in superficial bladder cancer;Martínez-Piñeiro;BJU Int,2002

5. Has a 3-fold decreased dose of bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial;Martinez-Pineiro;J Urol,2005

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Protein-Based Predictive Biomarkers to Personalize Neoadjuvant Therapy for Bladder Cancer—A Systematic Review of the Current Status;International Journal of Molecular Sciences;2024-09-13

2. Adverse drug reactions of intravesical instillation therapy for bladder cancer: based on FDA adverse event reporting system;Expert Opinion on Drug Safety;2024-08-22

3. Epirubicin and Non-Muscle Invasive Bladder Cancer Treatment: A Systematic Review;Journal of Clinical Medicine;2024-06-27